![image](https://acuraip.com/wp-content/uploads/2022/04/quality-2-scaled-e1650274396816.jpeg)
We never give up on quality
About Us
We are an Intellectual Property (IP) consulting firm providing end-to-end services for a range of IP requirements. The team members are primarily alumni of IIT Kharagpur Law School and include highly qualified techno-legal professionals with dual degrees in engineering and intellectual property law.
The team consists of professionals with expertise in the fields of electronics & electrical engineering, biotechnology, computer science, and mechanical engineering. Furthermore, we have significant experience in working with clients ranging from start-ups to Fortune 500 companies helping them protect their intellectual property across multiple jurisdictions.
Our team members have drafted and prosecuted hundreds of patent applications, resulting in granted patents in India, the US, and the EU. In addition, the team members have considerable expertise in trademark, copyright, design registration, and litigation.
The Team
Meet Our Team
Testimonials
Our clients share their experience
![client image](https://acuraip.com/wp-content/uploads/2023/01/Sightgain.png)
AcuraIP was the perfect solution for our patent search and application needs. They took us from idea, confirmed its originality through search, helped draft and refine it into the language of USPTO, and stepped us through the whole process. Very professional and responsive. Both of our patents have been approved! Patent No: US11368480B2, US11438367B2
Christian Sorensen, CEO, SightGain Inc., USA
![client image](https://acuraip.com/wp-content/uploads/2022/04/round-avatar-2-1-e1650303363236.png)
I’ve worked with AcuraIP for 2 years on strategic IP submissions in the the very competitive global automotive video arena and was very pleased when he was able to land a very thorough utility patent that will protect our product for years to come. Patent No: US11558584B2
Chris Pritchard, CEO, Nextpassenger.com, USA
![client image](https://acuraip.com/wp-content/uploads/2022/04/raphel-e1650304877112.png)
AcuraIP helped me secure my patent as well as trademark. I highly recommend their service. Patent No: US11351561B2
John Hedelin, Entrepreneur, Netherlands
![client image](https://acuraip.com/wp-content/uploads/2023/06/Screenshot-2023-06-07-at-10.01.09-AM.png)
We initially partnered with Acura IP to help with a patent search and opinion report for a new medical device we wanted to bring to the market. The quality of content and speed of their research exceeded expectations and earned our trust immediately. Acura IP guided and supported us along our entire IP patent journey - from idea to patent grant. I would highly recommend Acura IP as a trusted and knowledgeable partner for all your patent needs.
Wes Anderson, Owner, Clarion Solutions Group, USA
![client image](https://acuraip.com/wp-content/uploads/2023/09/airtime-e1693567607921.png)
If you're looking for a patent team that combines expertise, affordability, and a genuine commitment to client satisfaction, look no further than Team Acura IP. Their 5 Star reviews are genuine and really reflect their quality.
Daniel Kunz, CEO, Airtime Ltd, Switzerland
Insights
What’s Happening?
Dive deep into the latest insights from the world of Intellectual Property
Form 27 – Understanding Form 27 for Patentees and Licensees in the Post-2024 Amendment
Recent amendments to the Indian Patent Rules in 2024 have streamlined Form 27, a document patentees and licensees use to report patent utilization. The filing frequency is now every three financial years, and patentees only need to provide an approximate value of revenue accrued from the patented invention. This reduces the compliance burden for patent holders in India.
Read More![A detailed legal analysis of a recent patent case. The article explores the interpretation of Section 3(i) of the Indian Patents Act, focusing on diagnostic methods. The court's decision, key arguments presented by the parties, and the technical aspects of the patent are discussed. The judgment emphasizes the distinction between diagnostic and non-diagnostic tests, highlighting the need for a case-by-case evaluation. The article delves into the complexities of patent eligibility, providing insights into the legal reasoning and technological considerations involved in the case](https://acuraip.com/wp-content/uploads/2023/10/Interpretation-of-Section-3i-of-the-Indian-Patent-Act-1970-in-the-Context-of-Non-Invasive-Prenatal-Testing-1024x576.jpg)
Interpretation of Section 3(i) of the Indian Patent Act, 1970 in the Context of Non-Invasive Prenatal Testing
Introduction The advent of Non-Invasive Prenatal Testing (NIPT) has revolutionized prenatal diagnostics, enabling expectant parents to assess the genetic health of the fetus without invasive procedures. However, the eligibility of such diagnostic methods for patent protection, especially in light of Section 3(i) of the Indian Patent Act, 1970 (as amended) has been a subject of […]
Read More![generic medicine vs branded medicine](https://acuraip.com/wp-content/uploads/2023/09/Generic-Medicines.jpeg)
Branded Medicines vs. Generic Medicines: The Role of Patents
In the pharmaceutical industry, the distinction between branded and generic medicines is an essential one. Understanding this distinction is crucial not just for medical professionals and patients, but for legal practitioners who navigate the complex world of pharmaceutical patents. This article seeks to provide a clear overview of branded and generic medicines and the role played by patents in their development and distribution.
Read MoreOffice
Locations
Patent
Projects
Trademark
Projects
We are here to help you
Talk to us or write to us to get your concerns addressed right away!!